1887

Abstract

Chronic mucocutaneous candidiasis constitutes a heterogeneous group of syndromes, characterized by non-invasive infection of the skin, nails and mucosal membranes by the fungus spp. Although symptoms are heterogeneous, in all cases there is a reduction in protective cytokines, favouring the development of disease. The normal role of cytokines in skin lesions is not well understood. The present study aimed to investigate the progression of disease, understand specific cellular and molecular components involved in immunity to and determine the balance between pro- and anti-inflammatory cytokines over the course of cutaneous infection in immunocompetent mice. BALB/c mice (five per group) were inoculated with 5 × 10 pseudohyphae in the deep dermis of the paw and analysed over 1–14 days post-infection. The contralateral paws were used for negative controls. Haematoxylin and eosin staining of skin sections during infection was performed to analyse structural modifications to the epidermis such as hyperplasia, and infiltration of neutrophils and fibroblasts in the dermis. The cytokine populations were determined by capture ELISA using popliteal lymph node tissue. Pro-inflammatory cytokines (IL-6, TNF-α, IL-12, IFN-γ and IL-17) were detected at significant levels during the initial phase of cutaneous infection and correlated with the rapid elimination of . Anti-inflammatory cytokines (IL-13, IL-4, IL-10 and transforming growth factor-β) were detected on day 4 post-infection, and prevented exacerbation of inflammation and participated in healing of lesions. Thus, a balance between pro- and anti-inflammatory cytokines was fundamental for the resolution of infection. Importantly, these findings broaden our understanding of the immune mechanisms involved in chronic cutaneous candidiasis.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000095
2015-08-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jmm/64/8/810.html?itemId=/content/journal/jmm/10.1099/jmm.0.000095&mimeType=html&fmt=ahah

References

  1. Ashman R.B., Vijayan D., Wells C.A. 2011; IL-12 and related cytokines: function and regulatory implications in Candida albicans infection. Clin Dev Immunol 2011:686597 [View Article][PubMed]
    [Google Scholar]
  2. Barrientos S., Stojadinovic O., Golinko M.S., Brem H., Tomic-Canic M. 2008; Growth factors and cytokines in wound healing. Wound Repair Regen 16:585–601 [View Article][PubMed]
    [Google Scholar]
  3. Campois T.G., Zucoloto A.Z., Quirino G.F., Custodio L.A., Conchon-Costa I., Araujo E.J., Svidizinski T.I., Felipe I. 2013; Cutaneous candidiasis in BALB/c mice. In International Congress of Immunology Milan, Italy, 22–27 August 2013, abstract. 10.3389/conf.fimmu.2013.02.00241
    [Google Scholar]
  4. Cenci E., Mencacci A., Del Sero G., d'Ostiani C.F., Mosci P., Bacci A., Montagnoli C., Kopf M., Romani L. 1998; IFN-(is required for IL-12 responsiveness in mice with Candida albicans infection. J Immunol 161:3543–3550[PubMed]
    [Google Scholar]
  5. Chehimi J., Elder M., Greene J., Noroski L., Stiehm E.R., Winkelstein J.A., Sullivan K.E. 2001; Cytokine and chemokine dysregulation in hyper-IgE syndrome. Clin Immunol 100:49–56 [View Article][PubMed]
    [Google Scholar]
  6. Collins S.M., Dominguez M., Ilmarinen T., Costigan C., Irvine A.D. 2006; Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. Br J Dermatol 154:1088–1093 [View Article][PubMed]
    [Google Scholar]
  7. Conti H.R., Shen F., Nayyar N., Stocum E., Sun J.N., Lindemann M.J., Ho A.W., Hai J.H., Yu J.J., other authors. 2009; Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 206:299–311 [View Article][PubMed]
    [Google Scholar]
  8. Custodio L.A., Loyola W., Conchon-Costa I., da Silva Quirino G.F., Felipe I. 2011; Protective effect of Artin M from extract of Artocarpus integrifolia seeds by Th1 and Th17 immune response on the course of infection by Candida albicans.. Int Immunopharmacol 11:1510–1515[PubMed] [CrossRef]
    [Google Scholar]
  9. de Carvalho P.G.C., Custódio L.A., Conchon-Costa I., Jesus Andrade C.G.T., Quirino G.F.S., de Almeida R.S.C., Felipe I. 2012; Concanavalin-A induces IL-17 production during the course of Candida albicans infection. FEMS Immunol Med Microbiol 64:273–279 [View Article][PubMed]
    [Google Scholar]
  10. Eming S.A., Krieg T., Davidson J.M. 2007; Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol 127:514–525[PubMed] [CrossRef]
    [Google Scholar]
  11. Eyerich K., Rombold S., Foerster S., Behrendt H., Hofmann H., Ring J., Traidl-Hoffmann C. 2007; Altered, but not diminished specific T cell response in chronic mucocutaneous candidiasis patients. Arch Dermatol Res 299:475–481[PubMed] [CrossRef]
    [Google Scholar]
  12. Eyerich K., Foerster S., Rombold S., Seidl H.P., Behrendt H., Hofmann H., Ring J., Traidl-Hoffmann C. 2008 Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22.J Invest Dermatol 128:2640–2645[PubMed]
    [Google Scholar]
  13. Fichtner-Feigl S., Strober W., Kawakami K., Puri R.K., Kitani A. 2006; IL-13 signaling through the IL-13α2 receptor is involved in induction of TGF-1 production and fibrosis. Nat Med 12:99–106 [View Article][PubMed]
    [Google Scholar]
  14. Gordon S. 2003; Alternative activation of macrophages. Nat Rev Immunol 3:23–35 [View Article][PubMed]
    [Google Scholar]
  15. Huppler A.R., Bishu S., Gaffen S.L. 2012; Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy. Arthritis Res Ther 14:217–226[PubMed] [CrossRef]
    [Google Scholar]
  16. Kagami S., Rizzo H.L., Kurtz S.E., Miller L.S., Blauvelt A. 2010; IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans . J Immunol 185:5453–5462[PubMed] [CrossRef]
    [Google Scholar]
  17. Kaviratne M., Hesse M., Leusink M., Cheever A.W., Davies S.J., McKerrow J.H., Wakefield L.M., Letterio J.J., Wynn T.A. 2004; IL-13 activates a mechanism of tissue fibrosis that is completely TGF-βindependent. J Immunol 173:4020–4029 [View Article][PubMed]
    [Google Scholar]
  18. Kim Y.J., Carvalho F.C., Souza J.A.C., Gonçalves P.C.G., Nogueira A.V.B., Spolidório L.C., Roque-Barreira M.C., Cirelli J.A. 2013; Topical application of the lectin Artin M accelerates wound healing in rat oral mucosa by enhancing TGF-(and VEGF production. Wound Repair Regen 21:456–463 [View Article][PubMed]
    [Google Scholar]
  19. Kirkpatrick C.H. 2001; Chronic mucocutaneous candidiasis. Pediatr Infect Dis J 20:197–206[PubMed] [CrossRef]
    [Google Scholar]
  20. Kobrynski L.J., Tanimune L., Kilpatrick L., Campbell D.E., Douglas S.D. 1996; Production of T-helper cell subsets and cytokines by lymphocytes from patients with chronic mucocutaneous candidiasis. Clin Diagn Lab Immunol 3:740–745[PubMed]
    [Google Scholar]
  21. Lilic D., Gravenor I., Robson N., Lammas D.A., Drysdale P., Calvert J.E., Cant A.J., Abinun M. 2003; Deregulated production, of protective cytokines in response to Candida albicans infection in patients with chronic mucocutaneous candidiasis. Infect Immun 71:5690–5699 [View Article][PubMed]
    [Google Scholar]
  22. Romani L. 2004; Immunity to fungal infections. Nat Rev Immunol 4:1–23 [View Article][PubMed]
    [Google Scholar]
  23. van de Veerdonk F.L., Plantinga T.S., Hoischen A., Smeekens S.P., Joosten L.A., Gilissen C., Arts P., Rosentul D.C., Carmichael A.J., other authors. 2011; STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med 365:54–61 [View Article][PubMed]
    [Google Scholar]
  24. van der Graaf C.A.A., Netea M.G., Drenth I.P., te Morsche R.H., van der Meer J.W.M., Kullberg B.J. 2003; Candida-specific interferon-(deficiency and Toll-like receptor polymorphisms in patients with chronic mucocutaneous candidiasis. Neth J Med 61:365–369[PubMed]
    [Google Scholar]
  25. Yu J.J., Gaffen S.L. 2008; Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity. Front Biosci 13:170–177[PubMed] [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000095
Loading
/content/journal/jmm/10.1099/jmm.0.000095
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error